Mesenchymal stem cell therapy in pulmonary fibrosis: a meta-analysis of preclinical studies

Mesenchymal stem cell therapy in pulmonary fibrosis: a meta-analysis of preclinical studies

Abstract Background Pulmonary fibrosis (PF) is a devastating disease characterized by remodeling of lung architecture and abnormal deposition of fibroblasts in parenchymal tissue and ultimately results in respiratory failure and death. Preclinical studies suggest that mesenchymal stem cell (MSC) adm...

Full description

Bibliographic Details
Main Authors: Deng-Yuan Li, Ru-Fang Li, Dan-Xiong Sun, Dan-Dan Pu, Yun-Hui Zhang
Format: Article
Language:English
Published: BMC 2021-08-01
Series:Stem Cell Research & Therapy
Subjects:
Pulmonary fibrosis
Mesenchymal stem cell
Preclinical studies
Therapy
Meta-analysis
Online Access:https://doi.org/10.1186/s13287-021-02496-2

Internet

https://doi.org/10.1186/s13287-021-02496-2

Similar Items